Effects of valsartan on neuroprotection and neurogenesis after ischemia

NeuroReport

Volumn 22, Issue 8, 2011, Pages 385-390

  Wakai, Takuma ^a   Yoshioka, Hideyuki ^a   Yagi, Takashi ^a   Kato, Tatsuya ^a   Kinouchi, Hiroyuki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Angiotensin II type 1 receptor blocker; apoptosis; neurogenesis; neuroprotection

Indexed keywords

CYTOCHROME C; SUPEROXIDE; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE; BRAIN ISCHEMIA; CYTOSOL; DRUG ACTIVITY; FOREBRAIN; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; MITOCHONDRIAL MEMBRANE; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN ISCHEMIA; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; NEUROGENESIS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLES; VALINE;

EID: 79955618400     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328346be84     Document Type: Article

References (22)

1. Sawada T, Yamada H, Dahlof B, Matsubara H. Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART study. Eur Heart J 2009; 30:2461-2469.
2. Mochizuki S, Dahlof B, Shimizu M, Ikewaki K, Yoshikawa M, Taniguchi I, et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): A randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 2007; 369:1431-1439. (Pubitemid 46635780)
3. Sugawara T, Kinouchi H, Oda M, Shoji H, Omae T, Mizoi K. Candesartan reduces superoxide production after global cerebral ischemia. Neuroreport 2005; 16:325-328. (Pubitemid 40434559)
4. Mogi M, Li JM, Iwanami J, Min LJ, Tsukuda K, Iwai M, et al. Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 2006; 48:141-148. (Pubitemid 44297536)
5. Iwai M, Liu HW, Chen R, Ide A, Okamoto S, Hata R, et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 2004; 110:843-848. (Pubitemid 39096013)
6. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: Implications for cell death. Annu Rev Pharmacol Toxicol 2007; 47:143-183.
7. Niizuma K, Yoshioka H, Chen H, Kim GS, Jung JE, Katsu M, et al. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta 2010; 1802:92-99.
8. Kokaia Z, Lindvall O. Neurogenesis after ischaemic brain insults. Curr Opin Neurobiol 2003; 13:127-132. (Pubitemid 36197937)
9. Schutz S, Le Moullec JM, Corvol P, Gasc JM. Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol 1996; 149:2067-2079. (Pubitemid 26415223)
10. Sakata A, Mogi M, Iwanami J, Tsukuda K, Min LJ, Fujita T, et al. Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function. Brain Res 2009; 1300:14-23.
11. Rodriguez-Pallares J, Quiroz CR, Parga JA, Guerra MJ, Labandeira-Garcia JL. Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors. Eur J Neurosci 2004; 20:1489-1498. (Pubitemid 39274033)
12. Siragy HM. Angiotensin receptor blockers: How important is selectivity? Am J Hypertens 2002; 15:1006-1014. (Pubitemid 35217410)
13. Yoshioka H, Sugita M, Kinouchi H. Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia. Neurosci Lett 2009; 461:266-270.
14. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, et al. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 1998; 18:205-213. (Pubitemid 28046782)
15. Fujimura M, Morita-Fujimura Y, Murakami K, Kawase M, Chan PH. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1998; 18:1239-1247. (Pubitemid 28509838)
16. Monteiro P, Duarte AI, Goncalves LM, Providencia LA. Valsartan improves mitochondrial function in hearts submitted to acute ischemia. Eur J Pharmacol 2005; 518:158-164. (Pubitemid 41133640)
17. de Cavanagh EM, Toblli JE, Ferder L, Piotrkowski B, Stella I, Inserra F. Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine. Am J Physiol Regul Integr Comp Physiol 2006; 290:R1616-R1625. (Pubitemid 43830828)
18. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 2007; 87:245-313. (Pubitemid 46209993)
19. Yamamoto E, Tamamaki N, Nakamura T, Kataoka K, Tokutomi Y, Dong YF, et al. Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke 2008; 39:3049-3056.
20. Inaba S, Iwai M, Tomono Y, Senba I, Furuno M, Kanno H, et al. Exaggeration of focal cerebral ischemia in transgenic mice carrying human renin and human angiotensinogen genes. Stroke 2009; 40:597-603.
21. Engelhorn T, Goerike S, Doerfler A, Okorn C, Forsting M, Heusch G, et al. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 2004; 24:467-474. (Pubitemid 38455442)
22. Faraci FM, Lamping KG, Modrick ML, Ryan MJ, Sigmund CD, Didion SP. Cerebral vascular effects of angiotensin II: New insights from genetic models. J Cereb Blood Flow Metab 2006; 26:449-455.